NCT02037126View on ClinicalTrials.gov

Psilocybin-facilitated Treatment for Cocaine Use

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Psilocybin

this has been used in treating obsessive-compulsive disorders, cluster headaches, anxiety, and drug dependence.

DRUG

Diphenhydramine

This drug will be used as the control. Diphenhydramine is a histamine blocker.

Trial Locations (1)

35294

UAB Outpatient Clinical Research Unit, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02037126 - Psilocybin-facilitated Treatment for Cocaine Use | Biotech Hunter | Biotech Hunter